DEAR GUESTS,

It is my honor and privilege to invite you to the third international Forum "Life Sciences Baltics 2016", which will be held in Vilnius, Lithuania, on September 14-15, 2016. This bi-annual international science and business conference is the largest gathering of all life sciences specialists in the entire Central and Eastern Europe. Furthermore, with the special focus on three Baltic countries – Lithuania, Latvia and Estonia – the forum attracts numerous delegations from the leading countries, which are interested in discovering the Baltic region potential in the field of life sciences.

Since the future belongs to the bio-economy which is going to be based on the concrete results of the Life Sciences sector, it becomes crucial to turn it into a national priority. In order to improve international competitiveness and economic vibrancy in Lithuania, governmental institutions, and the whole science and business ecosystem join their forces to establish an open and friendly environment for attracting the progressive

mind, break-through ideas and forming the new effective networks with partners from all over the world.

Lithuania already hosts one of the most innovative hubs in Europe: 16 academic institutions, 15 most competent R&D centers along with the pool of over 15,000 specialists and researchers as well as nearly 200 companies operating in the sector, science parks, and innovation valleys. They provide the country with the most necessary tools to succeed in becoming one of the top high tech innovation centers in Europe or even the world. A nation with a population of only 3 million is among the top EU countries by the percentage of specialists with higher education. Universities currently train in physics and life sciences almost 9000 students, 1200 of these prospective inventors graduate every year. We have increased state financed places at universities and colleges for life science disciplines to ensure intellectual capacity for future growth. This decision is followed by prioritizing respective disciplines in the curriculum of high schools nation-wide.

It is important to highlight that The Forum enjoys high participation by local and international corporations and investors who attend this conference to notice tomorrow’s potential in today’s products. We are committed to promote a closer international cooperation between science and business in the fields of biotechnology, medical equipment, devices and pharmacy. The Forum also provides a platform for startups to meet

up with partners and investors. It is the ultimate place to be exposed in the clinical trials, meet the venture capital experts, boost ideas and begin cooperating further.

Join over 1000 business leaders and scientists at the Forum, meet potential partners, discover new opportunities, and share ideas for the new and prosperous future of humanity.

Our country would be delighted to welcome you at "Life Sciences Baltics 2016".

THIS IS THE LARGEST GATHERING OF ALL LIFE SCIENCES SPECIALISTS IN THE ENTIRE CENTRAL AND EASTERN EUROPE.

ALGIRDAS BUTKEVICIUS, PRIME MINISTER, REPUBLIC OF LITHUANIA

ˆ

BSR110 million

EU340 million

CIS 250 million

WHY BALTICS?

EUROPE’S PRIME LOCATION AND INFRASTRUCTURE

Crossroads of North, East and West3 Pam-European transport corridors4 modern international airports

TREND-SETTER DESTINATIONS IN EU

*BSR – The Baltic Sea Region CIS – The Commonwealth of Independent State

LATVIA

LITHUANIA

ESTONIA

EU STRUCTURAL FUNDS. Cooperation with Baltic companies enables access to the EU structural funds (only in Lithuania up to 1 billion EUR for the period of 2014-2020)

TALENTS. Region offers highly qualified talent pool

TAXES. Astonishing tax environment for R&D activities

COMPETITIVE SALARIES. Gross salaries in the life sciences sector are 2 to 3 times more competitive compared to Western Europe

START-UPS. A GROWING NUMBER OF START-UPS AND SMES HAVE ADVANCED PRODUCT PORTFOLIO AND WOULD LIKE TO ATTRACT PARTNERS FOR FINANCIAL INVESTMENTS

WHY BALTICS?

Data visualization has reached new peaks with the help of Latvians (Infogr.am)

Libraries house not only numerous hard copy books, but are being digitized and uploaded online 1ST IN ENTREPRENEURSHIP BY IMD

WORLD COMPETITIVENESS RANKING

Fastest public Wi-Fi in the world and leading upload broadband speed in the EU and top 5 globally

QUEUING IS AVOIDED BY USING ALMOST 100 STATE AND LOCAL GOVERNMENT E-SERVICES

1ST COUNTRY TO OFFER E-RESIDENCY - A TRANSNATIONAL DIGITAL IDENTITY AVAILABLE TO ANYONE IN THE WORLD INTERESTED IN ADMINISTERING A LOCATION-INDEPENDENT BUSINESS ONLINE

1st country in the world to hold nation-wide elections using i-Voting

More than 90% of the people complete their income tax return over the internet

ESTONIA: LATVIA: LITHUANIA:

WHY BALTICS?

Highest ICT literacy in the EU – 97% of students obtaining ICT skills in secondary schools

1st in CEE in University-Industry collaboration in R&D

LIFE SCIENCES IN ESTONIA:

LEADING SUBSECTOR: GENETICS & HEREDITY, CREATING 33,7% OF INDUSTRY PRODUCTION

UNIVERSITIES AND RESEARCH INSTITUTES WITH R&D IN BIOTECHNOLOGY AND LIFE SCIENCES

1866 66PH.D. GRADUATES PER YEAR

507 MASTER GRADUATES PER YEAR

1.841BACHELOR GRADUATES PER YEAR

AROUND

150 COMPANIES IN BIOTECHNOLOGY AND LIFE SCIENCES

THERE ARE 4 BIOMEDICAL CLUSTERS AND 3 BIOMEDICAL COMPETENCE CENTERS IN ESTONIA

9

ACADEMIC EXPERTS 28%

THE ANNUAL TURNOVER OF THE ESTONIAN BIOTECHNOLOGY IS GROWING AT A RATE OF 28%

33,7%

WILHELM OSTWALD IN CHEMISTRY IN 1909 FOR HIS WORK ON CATALYSIS, CHEMICAL EQUILIBRIA AND REACTION VELOCITIES

PAUL VALDEN WAS NOMINATED TWICE FOR THE NOBEL PRIZE AND IS A FOUNDER OF PHYSICAL ORGANIC CHEMISTRY

LEADING SUBSECTOR: PHARMACEUTICALS. IT IS THE LARGEST INDUSTRY SUB-SECTOR, CREATING 33% OF INDUSTRY PRODUCTION

CHEMICAL AND PHARMACEUTICAL SECTOR GIVES 9.4% (2010) OF GROSS DOMESTIC PRODUCT AND ACCOUNTS FOR 10% OF THE TOTAL NATIONAL EXPORT

TOTAL NUMBER OF LIFE SCIENCES COMPANIES, R&D CENTERS, UNIVERSITIES

5033%

NOBEL PRIZE WINNER:

NOBEL PRIZE WINNER:

LIFE SCIENCE SECTOR IS 4TH BY TURNOVER AMONG MANUFACTURING INDUSTRIES IN LATVIA

NR. 4

LIFE SCIENCES IN LATVIA:

ACHIEVED GROUND BREAKING RESULTS IN THE FIELDS OF:

PHARMACEUTICAL PROTEINS

CHEMISTRY

BIOCHEMISTRY OF ENZYMES AND NUCLEIC ACIDS

MOLECULAR BIOLOGY OF PROKARYOTE AND EUKARYOTE

Labor productivity in pharmaceuticals sector is almost 5 times (in 2011) higher than the overall economy’s labor productivity

LIFE SCIENCES IN LITHUANIA R&D SECTOR

15 000 R&D researchers and scientists in various fields

EXPENDITURES FOR R&D grew by 14% in 2014

R&D ORIENTED:

10TH IN THE WORLD FOR R&D PERSONNEL PER CAPITA (MAD, 2013)

3x

CURRENT SPOTLIGHT OF RESEARCH POINTED ON BIOINFORMATICS

FASTER GENES CUT, BASED ON ADVANCED ENZYMES METHODOLOGY, FOUND IN LITHUANIA

PRODUCTION IS EXPORTED TO OVER 100 COUNTRIES

TOTAL ANNUAL REVENUES EXCEED:

11% YEAR ON YEAR RISE IN R&D EXPENDITURE SINCE 2005 (LITHUANIAN STATISTICS, 2013)

16 RESEARCH CENTRES cooperating with both domestic and foreign biotechnology companies and universities

€ 75 000 000

23% ANNUAL GROWTH

OF TOTAL LITHUANIAN LASER PRODUCTION EXPORTED TO NEARLY 100 COUNTRIES (KEY MARKETS: USA, GERMANY, JAPAN)

LASERS

CLIENTS AND PARTNERS OF LITHUANIAN LASER MANUFACTURERS INCLUDE:

NASAThe Nuclear Research Centre in IsraelRutherford Laboratories in England 80% Berkeley University in the USA

The Livermore National Laboratory, etc

EVERY 10TH SCIENTIFIC LASER USED IN THE WORLD IS PRODUCED IN LITHUANIA

CONTINUOUS INDUSTRY GROWTH REACHING 20% PER YEAR

LITHUANIA, WITH 10% OF THE GLOBAL MARKET, IS ONE OF THE MAIN EXPORTER OF FEMTOSECOND* LASERS SYSTEMS IN THE WORLD*FEMTOSECOND = 0.000 000 000 000 000 1 S.

80%80% OF THE GLOBAL PRODUCTION OF ULTRA-FAST PARAMETRIC AMPLIFIERS

15 - 20%Laser manufacturing sector of Lithuania shows a 15 - 20% growth per year

MAIN EXPORT COUNTRIES ARE: UNITED KINGDOM FRANCE RUSSIA SPAIN USA

Research areas include biomedical diagnostics and monitoring systems, efficiency research of electronic security systems, analysis and synthesis of electronic devices, quality of electronic systems

“INDUSTRIAL ELECTRONICS, INCLUDING MEDICAL AND DEFENSE ELECTRONICS HAS BEEN A PREVALENT APPLICATION SECTOR IN ELECTRONICS MANUFACTURING WITH TELECOMMUNICATION EQUIPMENT BEING A KEY GROWING SEGMENT“

EDUCATIONMEDICAL DEVICES

1ST -IN EU FOR SHARE OF GRADUATES IN TOTAL POPULATION

-IN CEE FOR QUALITY OF MATH AND SCIENCE EDUCATION (WEF GLOBAL COMPETITIVENESS REPORT, 2014-2015)

9000 LIFE SCIENCE STUDENTS AT UNIVERSITIES AND COLLEGES

1200 GRADUATES EACH YEAR

€ 180 M

20122008 2014

€ 177 M

MEDICAL DEVICES EXPORTS (incl. re-exports) more than doubled since 2008

CLINICAL TRIALS BUSINESS-FRIENDLY ENVIRONMENT

STRATEGIC LOCATION

FAVORABLE TAX INCENTIVES FOR INVESTMENTS INTO R&D INCLUDING:

TRIPLE DEDUCTION: expenses incurred by companies while carrying out R&D can be deducted from taxable income tree times

SUPER-ACCELERATED DEPRECIATION: the acquisition price of fixed assets used in the R&D activities can be written-off within two years

INVESTMENTS INTO SUBSTANTIAL TECHNOLOGICAL IMPROVEMENTS, entitle companies to reduce taxable profits by 50%

FIND MORE AT WWW.LSB2016.COM

90 INTERNATIONAL PHARMA AND MEDICAL COMPANIES ARE CONDUCTING CLINICAL TRIALS IN LITHUANIA

ENDOCRINOLOGY GASTROENTEROLOGY RHEUMATOLOGY PULMONOLOGY INFECTOLOGY DERMATOLOGY UROLOGY PEDIATRIC SURGERY NEPHROLOGY CARDIOLOGY PSYCHIATRY HEMATOLOGY NEUROLOGY ONCOLOGY OPHTHALMOLOGY

Clinical trials in Lithuania cover a range of therapeutic areas

1200 SINCE 2006 THERE WERE 1200 CLINICAL TRIALS ONGOING IN THE COUNTRY

LIFE SCIENCES BALTICS NEW DESTINATION FOR LIFE SCIENCES TREND-SETTERS

LIFE SCIENCES BALTICS 2016 FOCUS ON:

AGE-RELATED DESEASES

MOLECULAR MEDICINE

BIO-BANKING

PRECLINICAL AND CLINICAL TRIALS

REGENERATIVE MEDICINE MEDICAL DEVICES

TECHNOLOGY TRANSFER AND INNOVATION MANAGEMENT

PHARMACEUTICALS AND BIOPHARMACEUTICALS

Within 2012 and 2014:

100 LITHUANIAN AND FOREIGN COMPANIES

B2B MEETINGS

3000

COUNTRIES

VISITORS FROM

AROUND 40

1900

ATTENDEES

EXHIBITORS

3rd Life Sciences Baltics 2016 is the only international forum in the Baltic region for world-class biotechnology, pharmaceutical and medical experts from around the world, reoccurring every two years.

DISCOVER ENORMOUS POTENTIAL IN THE FIELD OF LIFE SCIENCES IN LITHUANIA AND THE BALTIC REGION – THE GATEWAY TO EMERGING MARKETS

WHY A MUST?

MORE THAN 1000 KEY SECTOR PLAYERS AND DECISION MAKERS FROM MORE THAN 40 COUNTRIES (INCLUDING DELEGATIONS FROM US, ISRAEL, EU), REGULATORY BODIES AND GOVERNMENT REPRESENTATIVES

TALENT POOL AND STATE-OF-THE-ART SCIENTIFIC INFRASTRUCTURE OF THE BALTIC COUNTRIES

EU STRATEGY, DIRECTIONS AND FUNDING OPPORTUNITIES

NOBEL PRIZE WINNERS AND GLOBALLY ACCLAIMED SPEAKERS

1

2 4

5

6

3 FOCUS ON NETWORKING AND ESTABLISHING PARTNERSHIPS

INVESTOR-READY STARTUPS

It provides a unique opportunity to explore the new horizons of partnerships, exchange ideas and seek progress through networking.

To arrange a meeting please contact us:info@lsb2016.com, www.lsb2016.com

Enterprise Lithuania offers high quality services meeting business needs and expectations. The knowledge and expertise of our professional team, gained through direct dealing with the country’s companies and exporters, will help you to find the best and most reliable suppliers of products, services and technologies in Lithuania. We aim at finding a reliable and long-term partners. We work locally, but thing globally. A multicultural approach helps to better understand and evaluate the needs and interests of foreign clients.

For more information visit: www.enterpriselithuania.com

Main organizer:

SAVE THE DATE!SEPTEMBER 14-15, 2016